World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
125
Citations
81875
World Ranking
102
National Ranking
11

Medicine

D-Index
131
Citations
88038
World Ranking
2350
National Ranking
247

Andrew N. Phillips publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Andrew N. Phillips sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 778 publications — 99th percentile

99% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Andrew N. Phillips D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Andrew N. Phillips sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 125 D-Index — 98th percentile

98% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Andrew N. Phillips is affiliated with University College London in the United Kingdom. Their research primarily focuses on the field of Medicine, with particular emphasis on Infectious Diseases, Epidemiology, Economics and Econometrics, Emergency Medicine, and Sociology and Political Science.

The scientist's work covers a range of topics related to HIV/AIDS research and public health interventions, including:

  • HIV/AIDS Research and Interventions
  • HIV, Drug Use, Sexual Risk
  • HIV-related health complications and treatments
  • HIV/AIDS drug development and treatment
  • Global Maternal and Child Health
  • HIV/AIDS Impact and Responses
  • Sex work and related issues

Andrew N. Phillips has contributed to several notable recent papers, such as:

  • "A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19," New England Journal of Medicine, 2020
  • "Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple mathematical models," The Lancet HIV, 2020
  • "Universal weekly testing as the UK COVID-19 lockdown exit strategy," The Lancet, 2020
  • "Tixagevimab-cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial," The Lancet Respiratory Medicine, 2022
  • "Three lessons for the COVID-19 response from pandemic HIV," The Lancet HIV, 2020

Frequent co-authors collaborating with Andrew N. Phillips include:

  • Paul Revill
  • Valentina Cambiano
  • Timothy B. Hallett
  • Alison Rodger
  • Tim Colbourn

The scientist regularly publishes in a variety of academic venues, with the most frequent being:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • The Lancet HIV
  • The Lancet Global Health
  • SSRN Electronic Journal
  • PLoS ONE

Andrew N. Phillips is also an author of academic books, including a publication by Princeton University Press titled Outsourcing Empire (2020).

Best Publications

  • CD4+ count-guided interruption of antiretroviral treatment.

    Wafaa El-Sadr;Wafaa El-Sadr;Jens D Lundgren;James Neaton;Fred Gordin

  • Initiation of antiretroviral therapy in early asymptomatic HIV infection

    Sean Emery;Shweta Sharma;Gerd Fätkenheuer;Josep M. Llibre

  • Combination antiretroviral therapy and the risk of myocardial infarction

    Nina Friis-Møller;Caroline A Sabin;Rainer Weber;Antonella d'Arminio Monforte

  • Meta-analysis: Principles and procedures

    Matthias Egger;George Davey Smith;Andrew N Phillips

  • Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.

    Sheena McCormack;David T. Dunn;Monica Desai;David I. Dolling

  • Class of antiretroviral drugs and the risk of myocardial infarction.

    Nina Friis-Moller;Peter Reiss;Caroline A. Sabin;Rainer Weber

  • Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.

    Matthias Egger;Margaret May;Geneviève Chene;Andrew N. Phillips

  • Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy

    Alison J. Rodger;Valentina Cambiano;Tina Bruun;Pietro Vernazza

  • Changing patterns of mortality across Europe in patients infected with HIV-1.

    A Mocroft;S Vella;TL Benfield;A Chiesi

  • Decline in the AIDS and death rates in the EuroSIDA study: an observational study

    A Mocroft;B Ledergerber;C Katlama;O Kirk

  • Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study

    Rainer Weber;Caroline A Sabin;Nina Friis-Møller;Peter Reiss

  • Cardiovascular disease risk factors in HIV patients - association with antiretroviral therapy. Results from the DAD study

    Nina Friis-Møller;Rainer Weber;Peter Reiss;Rodolphe Thiebaut

  • Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration

    Caroline Sabin;Signe Westring Worm;Rainer Weber

  • Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration

    Colette J Smith;Lene Ryom;Rainer Weber;Philippe Morlat

  • Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study

    Alison J Rodger;Valentina Cambiano;Tina Bruun;Pietro Vernazza

  • British HIV Association guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008

    B G Gazzard;Jane Anderson;Abdel Babiker;Marta Boffito

  • Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.

    Jonathan A C Sterne;Margaret May;Dominique Costagliola;Frank de Wolf

  • HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity.

    Steven G Deeks;Andrew N Phillips

  • Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study

    Signe Westring Worm;Caroline Sabin;Rainer Weber;Peter Reiss

  • Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients.

    A d'Arminio Monforte;A C Lepri;G Rezza;P Pezzotti

Frequent Co-Authors

Jens D. Lundgren
Jens D. Lundgren Rigshospitalet
Caroline Sabin
Caroline Sabin University College London
Peter Reiss
Peter Reiss University of Amsterdam
Amanda Mocroft
Amanda Mocroft University College London
Antonella d'Arminio Monforte
Antonella d'Arminio Monforte University of Milan
Margaret Johnson
Margaret Johnson The Royal Free Hospital
Rainer Weber
Rainer Weber University of Zurich
Martin Fisher
Martin Fisher University of Sussex
Wafaa El-Sadr
Wafaa El-Sadr Columbia University
Alison Rodger
Alison Rodger University College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to various healthcare and research careers. For those interested in the administrative and coding side of healthcare, pursuing a cpc certification can provide specialized skills in medical coding and billing, offering a stable career with competitive salary prospects.

Another promising option is becoming a health information manager. This role involves overseeing patient data management and ensuring compliance with healthcare regulations. To understand the role better, you can explore the health information management job description and salary.

For those wanting to advance academically while working, there are excellent online health information management degree programs cahiim accredited. These programs offer the flexibility to study remotely and meet industry accreditation standards, making them ideal for career growth.

Additionally, the demand for fast training options has led to the rise of the best fastest online medical billing and coding certificate programs. These certificates provide an accelerated pathway into medical billing and coding careers, supporting quick entry into the healthcare job market.

Best Scientists Citing Andrew N. Phillips

Trending Scientists

Recently Published Articles